Only Lyme disease vaccine in development moves to phase 3 trials
Participants will receive three doses of the vaccine, called VLA15, or a placebo, followed by a booster dose. “With rising global rates of Lyme disease, it’s more important than ever to give people a new option to protect themselves against the disease,” said Annaliesa Anderson, senior vice president and chief research officer and of vaccine … Read more